Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TARGET OF VGSC β3 PROTEIN FOR PREVENTION, TREATMENT AND DIAGNOSTIC DETECTION OF CANCERS
Document Type and Number:
WIPO Patent Application WO/2016/011840
Kind Code:
A1
Abstract:
Disclosed are an inhibitor of a VGSC β3 protein and uses thereof; a method for diagnosing, preventing and treating cancers using the VGSC β3 protein or an inhibitor thereof; and a method for screening anti-tumour drugs using the VGSC β3 protein or regulatory sequences thereof.

Inventors:
LIU YANFENG (CN)
CUI YONG (CN)
ZHANG JINGHAI (CN)
Application Number:
PCT/CN2015/079356
Publication Date:
January 28, 2016
Filing Date:
May 20, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SHENYANG PHARMACEUTICAL (CN)
International Classes:
A61P35/00; C12Q1/68; C07K14/705
Foreign References:
US20120082659A12012-04-05
Other References:
KATSUYA, A. ET AL.: "Identification of SCN3B As a Novel P53-Inducible Proapoptotic Gene", ONCOGENE, vol. 23, 31 December 2004 (2004-12-31), pages 7791 - 7798
WILLIAM, J.B. ET AL.: "Na+ Channel ß Subunits: Overachievers of the Ion Channel Family", FRONTIERS IN PHARMACOLOGY, vol. 2, no. 53, 28 September 2011 (2011-09-28), pages 1 - 11
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
北京市中咨律师事务所 (CN)
Download PDF: